KOGA Mitsuhisa 古賀允久

Researcher Number	60570801
Other IDs
Affiliation (Current)	2025: 福岡大学, 薬学部, 准教授
Affiliation (based on the past Project Information) *help	2019 – 2024: 福岡大学, 薬学部, 准教授 2011 – 2018: 福岡大学, 薬学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related / Medical pharmacy / Pharmacology in pharmacy Except Principal Investigator Basic Section 47060:Clinical pharmacy-related / Pediatrics / Basic Section 54020:Connective tissue disease and allergy-related / Basic Section 47040:Pharmacology-related / General medical chemistry / General pharmacology
Keywords	Principal Investigator バレニクリン / 心血管イベント / 副作用 / 慢性閉塞性肺疾患 / 大動脈瘤・解離 / 禁煙補助薬バレニクリン / 有害作用 / ナルメフェン / 動脈硬化症 / 肺胞マクロファージ … More / OPN / 肺保護作用 / COPD / alpha7 nAChR / バレンクリン / 心血管 … More Except Principal Investigator 川崎病 / シアル酸 / Fc / 免疫グロブリン / カンジダ / カンジダアルビカンス / リコンビナント / NAFLD / NASH / プロドラッグ / 薬物有害作用 / バレニクリン / 高尿酸血症 / 動脈硬化 / PDGFR / PDGFRβ / 脳ペリサイト / グルタミン酸 / 神経易興奮性 / ミクログリア / アストロサイト / てんかん / 頭部外傷 / ペリサイト / 更年期 / リポキシンA4 / LXA4 / COPD / エストロゲン / トランスレーショナルリサーチ / 汎血管炎 / Fab / IgG / 冠動脈起始部血管炎 / 大動脈基部血管炎 / 川崎病モデルマウス / モデルマウス / 脳血管性認知症 / オリゴデンドロサイト / シクロフィリンA / 白質障害 / 大脳白質 / 白質 / CD147 / 国際情報交流 / 血管炎 / JNK阻害薬 / マウスモデル / テネイシンC / JNK / 冠動脈瘤 Less

Mechanism of inhibiting aortic aneurysm formation and expansion by varenicline, a smoking cessation drugPrincipal Investigator
- Principal Investigator
  
  古賀允久
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Fukuoka University
Research for the development and clinical application of new recombinant immunoglobulin
- Principal Investigator
  
  吉兼由佳子
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54020:Connective tissue disease and allergy-related
- Research Institution
  Fukuoka University
新規ビタミンEエステル型プロドラッグによるNASHに関連した心血管リスク抑制効果
- Principal Investigator
  
  渡瀬大輔
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Fukuoka University
Mechanism of atherosclerotic plaque formation by nalmefene, an opioid modulator for the reduction of alcohol consumptionPrincipal Investigator
- Principal Investigator
  
  Koga Mitsuhisa
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Fukuoka University
The role of pericytes in the development of epileptogenesis after traumatic brain injury
- Principal Investigator
  
  TAKATA Fuyuko
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47040:Pharmacology-related
- Research Institution
  Fukuoka University
Exacerbation mechanism of atherosclerosis progression by varenicline in hyperuricemia
- Principal Investigator
  
  Yamauchi Atsushi
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Fukuoka University
Varenicline, a smoking cessation drug, improves alveolar expansion and inflammation in elastase-induced lung damagePrincipal Investigator
- Principal Investigator
  
  Koga Mitsuhisa
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pharmacology in pharmacy
- Research Institution
  Fukuoka University
Estrogen-induced alteration of chronic obstructive pulmonary disease regulated by SAA/LXA4 balance
- Principal Investigator
  
  Koji Tominaga
- Project Period (FY)
  2017 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General medical chemistry
- Research Institution
  Fukuoka University
Sialylated Fc as a novel therapeutic agent in the acute phase of Kawasaki disease
- Principal Investigator
  
  YOSHIKANE YUKAKO
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pediatrics
- Research Institution
  Fukuoka University
Adverse effect of varenicline on cardiovascular disease under chronic obstructive pulmonary disease conditionsPrincipal Investigator
- Principal Investigator
  
  Koga Mitsuhisa
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Fukuoka University
Function of CD147 in white matter lesions
- Principal Investigator
  
  Nishioku Tsuyoshi
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General pharmacology
- Research Institution
  Nagasaki International University
  Fukuoka University
Varenicline aggravates plaque formation through alpha7 nicotinic acetylcholine receptors in ApoE KO mice.Principal Investigator
- Principal Investigator
  
  KOGA Mitsuhisa
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Fukuoka University
JNK is Critical for Development of Candida albicans-induced Aneurysm in Mouse Model of Kawasaki Disease
- Principal Investigator
  
  YOSHIKANE Yukako
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pediatrics
- Research Institution
  Fukuoka University

All 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Other

All Journal Article Presentation Other

[Journal Article] Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages2020
- Author(s)
  Koga Mitsuhisa、Kanaoka Yuki、Inada Koshun、Omine Sai、Kataoka Yasufumi、Yamauchi Atsushi
- Journal Title
  
  Journal of Pharmacological Sciences
  
  Volume: 143 Issue: 2 Pages: 106-111
- DOI
  10.1016/j.jphs.2020.01.012
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08329, KAKENHI-PROJECT-20K07146
[Journal Article] Varenicline aggravates atherosclerotic plaque formation in nicotine-pretreated ApoE knockout mice due to enhanced oxLDL uptake by macrophages through downregulation of ABCA1 and ABCG1?expression2020
- Author(s)
  Koga Mitsuhisa、Kanaoka Yuki、Okamoto Mana、Nakao Yuki、Inada Koshun、Takayama Saki、Kataoka Yasufumi、Yamauchi Atsushi
- Journal Title
  
  Journal of Pharmacological Sciences
  
  Volume: 142 Issue: 1 Pages: 9-15
- DOI
  10.1016/j.jphs.2019.11.002
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08329
[Journal Article] Varenicline is a smoking cessation drug that blocks alveolar expansion in mice intratracheally administrated porcine pancreatic elastase.2018
- Author(s)
  Koga M, Kanaoka Y, Tashiro T, Hashidume N, Kataoka Y, Yamauchi A.
- Journal Title
  
  J Pharmacol Sci.
  
  Volume: 137 Pages: 224-229
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08329
[Journal Article] Varenicline promotes endothelial cell migration by lowering vascular endothelial-cadherin levels via the activated α7 nicotinic acetylcholine receptor-mitogen activated protein kinase axis.2017
- Author(s)
  Koga M, Kanaoka Y, Sugiyama K, Ohishi K, Ejima Y, Hisanaga M, Kataoka Y,　Yamauchi A
- Journal Title
  
  Toxicology
  
  Volume: 390 Pages: 1-9
- DOI
  10.1016/j.tox.2017.08.006
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08329
[Journal Article] Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α(7) nAChR in macrophages.2017
- Author(s)
  Kanaoka Y, Koga M, Sugiyama K, Ohishi K, Kataoka Y, Yamauchi A.
- Journal Title
  
  Toxicology
  
  Volume: 380 Pages: 62-71
- DOI
  10.1016/j.tox.2017.02.006
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K18948, KAKENHI-PROJECT-17K08329
[Journal Article] Elevated permeability of the blood-brain barrier in mice intratracheally2015
- Author(s)
  Takata F, Tominaga K, Koga M, Dohgu S, Futagami K, Yamauchi A, Kataoka Y.
- Journal Title
  
  J Pharmacol Sci.
  
  Volume: 129 Issue: 1 Pages: 78-81
- DOI
  10.1016/j.jphs.2015.08.008
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K18948, KAKENHI-PROJECT-25460236
[Journal Article] Varenicline aggravates plaque formation through α7 nicotinic acetylcholine receptors in ApoE KO mice.2014
- Author(s)
  Koga M, Kanaoka Y, Ohkido Y, Kubo N, Ohishi K, Sugiyama K, Yamauchi A, Kataoka Y
- Journal Title
  
  Biochem Biophys Res Commun.
  
  Volume: 455(3-4) Issue: 3-4 Pages: 194-7
- DOI
  10.1016/j.bbrc.2014.10.150
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25460236, KAKENHI-PROJECT-25860134
[Journal Article] BMP4 is increased in the aortas of diabetic ApoE knockout mice andenhances uptake of oxidized low density lipoprotein into peritoneal macrophages.2013
- Author(s)
  Koga M, Yamauchi A, Kanaoka Y, Jige R, Tsukamoto A, Teshima N, Nishioku T,Kataoka Y.
- Journal Title
  
  J Inflamm
  
  Volume: 10(1) Issue: 1 Pages: 32-32
- DOI
  10.1186/1476-9255-10-32
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25460236, KAKENHI-PROJECT-25460349, KAKENHI-PROJECT-25860134
[Journal Article] The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice.2013
- Author(s)
  Koga M, Engberding N, Dikalova AE, Chang KH, Seidel-Rogol B, Long JS, Lassègue B, Jo H, Griendling KK.
- Journal Title
  
  Am J Physiol Heart Circ Physiol.
  
  Volume: 305 Issue: 5 Pages: H747-H755
- DOI
  10.1152/ajpheart.00825.2012
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25860134
[Presentation] In vitro脂肪肝モデルに対するγ-トコトリエノールエステル型プロドラッグの有効性に関する研究2023
- Author(s)
  田島千春、渡瀬大輔、山田彩乃、後藤将太朗、瀬戸口修一、櫨川舞、古賀允久、松永和久、髙田二郎
- Organizer
  第40回日本薬学会九州山口支部大会
- Data Source
  KAKENHI-PROJECT-21K06659
[Presentation] γ-トコトリエノールエステル型プロドラッグを用いたin vitro肝線維化モデルに対する有効性及び薬物送達性の評価2023
- Author(s)
  浅海凪沙、渡瀬大輔、山田彩乃、後藤将太朗、瀬戸口修一、古賀允久、松永和久、髙田二郎
- Organizer
  日本薬剤学会第38年会
- Data Source
  KAKENHI-PROJECT-21K06659
[Presentation] 飲酒量低減薬ナルメフェンはスカベンジャー受容体CD36発現増加による酸化LDLマクロファージ内取り込みおよび動脈硬化巣形成を促進する2023
- Author(s)
  山田彩乃、古賀允久、稲田紘舜、山内淳史
- Organizer
  日本薬理学会第143回年会
- Data Source
  KAKENHI-PROJECT-20K07146
[Presentation] n vitro肝線維化モデルに対するγ-トコトリエノールエステル型プロドラッグの有効性及び薬物送達性の評価2023
- Author(s)
  米増彩音、渡瀬大輔、山田彩乃、後藤将太朗、瀬戸口修一、櫨川舞、古賀允久、松永和久、髙田二郎
- Organizer
  第40回日本薬学会九州山口支部大会
- Data Source
  KAKENHI-PROJECT-21K06659
[Presentation] Nalmefene, a reducing alcohol consumption drug, enhanced oxLDL uptake in macrophages and aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice.2022
- Author(s)
  古賀允久、稲田紘舜、山田彩乃、稲冨千夏、上村美結、寺本千紗、高田二郎、山内淳史
- Organizer
  第95回日本薬理学会年会
- Data Source
  KAKENHI-PROJECT-20K07146
[Presentation] モキシフロキサシンによるオステオポンチンを介した大動脈瘤・解離の増悪作用2021
- Author(s)
  稲田紘舜、古賀允久、山内淳史
- Organizer
  第94回日本薬理学会年会
- Data Source
  KAKENHI-PROJECT-20K07146
[Presentation] モキシフロキサシンによるマクロファージのオステオポンチン発現増加を介した大動脈瘤・解離のリスク上昇2020
- Author(s)
  稲田紘舜、古賀允久、片岡泰文、山内淳史
- Organizer
  第93回日本薬理学会年会
- Data Source
  KAKENHI-PROJECT-17K08329
[Presentation] COPDモデルマウスにおけるリポキシンA4に対するエストロゲンの影響2020
- Author(s)
  冨永宏治, 青野健太郎, 松本純一, 古賀允久, 山内淳史, 江川孝, 片岡泰文
- Organizer
  日本薬学会第140年会
- Data Source
  KAKENHI-PROJECT-17K08647
[Presentation] バレニクリンは、a7 nAChRを介して肺胞マクロファージにおけるosteopontinの発現を減少させる2019
- Author(s)
  古賀允久、稲田紘舜、田村茉由、萩原理子、森園好江、片岡泰文、山内淳史
- Organizer
  第92回日本薬理学会年会
- Data Source
  KAKENHI-PROJECT-17K08329
[Presentation] Dysregulation of the CNS supporting vascular and glial cells induces the late posttraumatic epilepsy in mice with mild traumatic brain injury.2018
- Author(s)
  Kenta Sakai, Fuyuko Takata, Shinya Dohgu, Mitsuhisa Koga, Ikuya Kimura, Atsushi Yamauchi, Yasufumi Kataoka
- Organizer
  18th World Congress of basic and clinical pharmacology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K06712
[Presentation] Varenicline, a smoking cessation drug, inhibited the alveolar expansion in mice intratracheally administrated porcine pancreatic elastase.2018
- Author(s)
  Mitsuhisa Koga
- Organizer
  第91回日本薬理学会年会・第18回国際薬理学・臨床薬理学会議
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K08329
[Presentation] Smoking cessation drug, varenicline, inhibited alveolar expansion in mice intratracheally administrated porcine pancreatic elastase2018
- Author(s)
  Koga M, Kanaoka Y, Kobayashi N, Inada K, Eto M, Takagi A, Kataoka Y, Yamauchi A.
- Organizer
  18th World Congress of basic and clinical pharmacology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K08329
[Presentation] Varenicline downregulates VE-cadherin expression and enhances HUVEC migration through α7 nAChR2017
- Author(s)
  古賀允久、金岡祐輝、橋爪渚、田代哲士、片岡泰文、山内淳史
- Organizer
  第90回日本薬理学会年会
- Place of Presentation
  長崎
- Year and Date
  2017-03-15
- Data Source
  KAKENHI-PROJECT-15K18948
[Presentation] Varenicline enhances oxLDL uptake into macrophages by increasing LOX-1 and CD36 scavenger receptor through α7 nAChR2017
- Author(s)
  金岡祐輝、古賀允久、片岡泰文、山内淳史
- Organizer
  第90回日本薬理学会年会
- Place of Presentation
  長崎
- Year and Date
  2017-03-15
- Data Source
  KAKENHI-PROJECT-15K18948
[Presentation] バレニクリンはマクロファージにおける酸化LDLによる泡沫化を促進する2016
- Author(s)
  金岡祐輝、古賀允久、山内淳史、片岡泰文
- Organizer
  第136回日本薬学会
- Place of Presentation
  横浜
- Year and Date
  2016-03-26
- Data Source
  KAKENHI-PROJECT-15K18948
[Presentation] バレニクリンはマクロファージにおけるoxLDLの取り込みを促進させる2015
- Author(s)
  金岡祐輝、古賀允久、山内淳史、片岡泰文
- Organizer
  第68回日本薬理学会西南部会
- Place of Presentation
  下関
- Year and Date
  2015-11-21
- Data Source
  KAKENHI-PROJECT-15K18948
[Presentation] 血管内皮細胞における禁煙補助薬バレニクリンの遊走作用2015
- Author(s)
  江島優佳、古賀允久、金岡祐輝、久永真未、田代哲士、橋爪渚、山内淳史、片岡泰文
- Organizer
  第68回日本薬理学会西南部会
- Place of Presentation
  下関
- Year and Date
  2015-11-21
- Data Source
  KAKENHI-PROJECT-15K18948
[Presentation] 川崎病冠動脈瘤形成予防薬開発;JNK阻害薬～汎血管炎モデルマウスを用いた検討～2014
- Author(s)
  吉兼由佳子、橋本淳一、古賀允久、長環、吉村耕一、今中恭子、廣瀬伸一
- Organizer
  第117回日本小児科学会学術集会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23591590
[Presentation] 禁煙補助薬バレニクリンによる心血管系有害事象2014
- Author(s)
  金岡祐輝、古賀允久、大石かおる、杉山慶太、江島優佳、久永真美、山内淳史、片岡泰文
- Organizer
  第67回日本薬理学会西南部会
- Place of Presentation
  北九州：産業医科大学
- Year and Date
  2014-11-23
- Data Source
  KAKENHI-PROJECT-25860134
[Presentation] ＢＭＰ４は、ＣＤ３６発現を増加させることによりマクロファージの酸化ＬＤＬ取り込みを促進させる。2014
- Author(s)
  Kanaoka Y, Koga M, Kubo N, Ohkido Y, Sugiyama K, Ohishi K, Yamauchi A, Kataoka Y
- Organizer
  第87回日本薬理学会年会
- Place of Presentation
  仙台
- Data Source
  KAKENHI-PROJECT-25860134
[Presentation] The role of tenascin C in an animal model of Kawasaki disease-related coronary artery aneurysm2013
- Author(s)
  Yukako Yoshikane, Junichi Hashimoto、Kyoko Imanaka、Mitsuhisa Koga、Tamaki Cho、Koichi Yoshimura、Yumiko Yamamoto、Hiroki Aoki、Shinichi Hirose
- Organizer
  The 19^<th> Asia-Pacific Conference of Cardiology (APCC 2013)
- Place of Presentation
  Thai
- Data Source
  KAKENHI-PROJECT-23591590
[Presentation] JNK阻害薬による動脈瘤形成の抑制川崎病類似汎血管炎モデルマウスを用いた検討2013
- Author(s)
  吉兼由佳子、吉村耕一、今中恭子、長環、古賀允久、山本由美子、青木弘樹、橋本淳一、上田誠、廣瀬伸一
- Organizer
  第49回小児循環器学会総会
- Place of Presentation
  東京(日本小児循環器学会雑誌29巻Suppl. Page168)
- Data Source
  KAKENHI-PROJECT-23591590
[Presentation] 川崎病類似汎血管炎モデルマウス病理組織の経時的変化化～テネイシンとの関連～2013
- Author(s)
  吉兼由佳子、橋本淳一、上田誠、長環、古賀允久、吉村耕一、山本由美子、今中恭子、廣瀬伸一
- Organizer
  第116回日本小児科学会学術集会
- Place of Presentation
  広島(日本小児科学会雑誌117巻2号Page333)
- Data Source
  KAKENHI-PROJECT-23591590
[Presentation] Tissue remodeling in vascular wall in Kawasaki disease-related vasculitis model mice2013
- Author(s)
  Yukako Yoshikane、Junichi Hashimoto、Kyoko Imanaka-Yoshida、Mitsuhisa Koga、Tamaki Cho、Koichi Yoshimura、Yumiko Yamamoto、Hiroki Aoki、Shinichi Hirose
- Organizer
  7^<th> Takao Symposium
- Place of Presentation
  Tokyo
- Data Source
  KAKENHI-PROJECT-23591590
[Presentation] The role of tenascin C in an animal model of Kawasaki disease-related coronary artery aneurysm.2013
- Author(s)
  Yukako Yoshikane, Junichi Hashimoto、Kyoko Imanaka、Mitsuhisa Koga、Tamaki Cho、Koichi Yoshimura、Yumiko Yamamoto、Hiroki Aoki、Shinichi Hirose
- Organizer
  19th Asia-Pacific Conference on Communications
- Place of Presentation
  タイ
- Data Source
  KAKENHI-PROJECT-23591590
[Presentation] c-Jun N-terminal kinase is a novel therapeutic target for controlling the development of Kawasaki disease-related arterial aneurysm2013
- Author(s)
  Yukako Yoshikane, Mitsuhisa Koga, Tamaki Cho, Kyoko Imanaka-Yoshida, Junichi Hashimoto, Hiroki Aoki, Koichi Yoshimura, Shinichi Hirose
- Organizer
  American Heart Association Scientific Sessions
- Data Source
  KAKENHI-PROJECT-23591590
[Presentation] JNK抑制による川崎病冠動脈瘤予防薬の開発～汎血管炎モデルマウスを用いた検討～2013
- Author(s)
  吉兼由佳子、古賀允久、長環、吉村耕一、今中恭子、橋本淳一、上田誠、山本由美子、青木浩樹、廣瀬伸一
- Organizer
  第33回日本川崎病学会
- Place of Presentation
  富山
- Data Source
  KAKENHI-PROJECT-23591590
[Presentation] 動脈炎におけるテネイシンCの役割～川崎病類似汎血管炎マウスモデルから～2012
- Author(s)
  吉兼由佳子、橋本淳一、今中恭子、古賀允久、長環、吉村耕一、山本由美子、青木浩樹、廣瀬伸一
- Organizer
  第11回心臓血管発生研究会
- Place of Presentation
  福島
- Data Source
  KAKENHI-PROJECT-23591590
[Presentation] バレニクリンによるα7nAChRを介する動脈硬化巣形成の増悪作用
- Author(s)
  金岡祐輝、古賀允久、大石かおる、杉山慶太、江島優佳、久永真未、山内淳史、片岡泰文
- Organizer
  第135回薬学会
- Place of Presentation
  神戸
- Year and Date
  2015-03-26 – 2015-03-28
- Data Source
  KAKENHI-PROJECT-25860134
[]
[]
[]

1. YAMAUCHI Atsushi (90341453)

# of Collaborated Projects: 4 results

# of Collaborated Products: 4 results
2. YOSHIKANE Yukako (00449927)

# of Collaborated Projects: 3 results

# of Collaborated Products: 9 results
3. CHO Tamaki (90131870)

# of Collaborated Projects: 2 results

# of Collaborated Products: 9 results
4. 原岡誠司 (40251053)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
5. 片岡泰文 (70136513)

# of Collaborated Projects: 2 results

# of Collaborated Products: 10 results
6. YOSHIDA Kyoko (00242967)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. YOSHIMURA Koichi (00322248)

# of Collaborated Projects: 1 results

# of Collaborated Products: 9 results
8. HASHIMOTO Junichi (90580291)

# of Collaborated Projects: 1 results

# of Collaborated Products: 9 results
9. Nishioku Tsuyoshi (90435115)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. Koji Tominaga (10509623)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
11. TAKATA Fuyuko (70412575)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
12. 金岡祐輝 (80761246)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 岩尾卓朗 (30846374)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 渡瀬大輔 (00580200)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
15. 稲田紘舜 (80881052)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 山田彩乃 (80909622)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. 伊東和俊 (10782831)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. Eguchi Mitsutoshi

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
19. Tameishi Masayuki

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. 吉田恭子

# of Collaborated Projects: 0 results

# of Collaborated Products: 9 results

KOGA Mitsuhisa 古賀 允久

Research Projects

Research Products

Co-Researchers

Mechanism of inhibiting aortic aneurysm formation and expansion by varenicline, a smoking cessation drugPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mechanism of atherosclerotic plaque formation by nalmefene, an opioid modulator for the reduction of alcohol consumptionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Varenicline, a smoking cessation drug, improves alveolar expansion and inflammation in elastase-induced lung damagePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Adverse effect of varenicline on cardiovascular disease under chronic obstructive pulmonary disease conditionsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Varenicline aggravates plaque formation through alpha7 nicotinic acetylcholine receptors in ApoE KO mice.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Varenicline aggravates atherosclerotic plaque formation in nicotine-pretreated ApoE knockout mice due to enhanced oxLDL uptake by macrophages through downregulation of ABCA1 and ABCG1?expression2020

KOGA Mitsuhisa 古賀允久